Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (301-310 of 344) with videos related to

Pageof 35
Sort By:
Thrombosis Research|February 4, 2023
Platelet function and soluble P-selectin in patients with primary immune thrombocytopeniaDino Mehic, Jennifer Machacek, Theresa Schramm, et al.
Plos One|January 5, 2017
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)Oliver Königsbrügge, Florian Posch, Marlies Antlanger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective CohortsAndrés Muñoz, Cihan Ay, Ella Grilz, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative ReviewLoris Wauthier, Julien Favresse, Michaël Hardy, et al.
Journal of Clinical Medicine|July 27, 2024
Predelivery Haemostatic Biomarkers in Women with Non-Severe Postpartum HaemorrhageClaire de Moreuil, Brigitte Pan-Petesch, Dino Mehic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Thrombosis and Haemostasis|February 1, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK StudyAlexander T Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Haematologica|May 4, 2019
Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumorsYohei Hisada, Steven P Grover, Anaum Maqsood, et al.
Journal of Thrombosis and Haemostasis : JTH|October 14, 2023
Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis DaySara A Malerba, Riccardo M Fumagalli, Cihan Ay, et al.
Scientific Reports|May 5, 2016
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammationStefan Stojkovic, Christoph Kaun, Jose Basilio, et al.
Pageof 35

Showing results (301-310 of 344) with videos related to

Sort By:
Pageof 35
Thrombosis Research|February 4, 2023
Platelet function and soluble P-selectin in patients with primary immune thrombocytopeniaDino Mehic, Jennifer Machacek, Theresa Schramm, et al.
Plos One|January 5, 2017
Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)Oliver Königsbrügge, Florian Posch, Marlies Antlanger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective CohortsAndrés Muñoz, Cihan Ay, Ella Grilz, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative ReviewLoris Wauthier, Julien Favresse, Michaël Hardy, et al.
Journal of Clinical Medicine|July 27, 2024
Predelivery Haemostatic Biomarkers in Women with Non-Severe Postpartum HaemorrhageClaire de Moreuil, Brigitte Pan-Petesch, Dino Mehic, et al.
Blood|September 15, 2022
The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia ACihan Ay, Katarina D Kovacevic, Daniel Kraemmer, et al.
Thrombosis and Haemostasis|February 1, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK StudyAlexander T Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Haematologica|May 4, 2019
Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumorsYohei Hisada, Steven P Grover, Anaum Maqsood, et al.
Journal of Thrombosis and Haemostasis : JTH|October 14, 2023
Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis DaySara A Malerba, Riccardo M Fumagalli, Cihan Ay, et al.
Scientific Reports|May 5, 2016
Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammationStefan Stojkovic, Christoph Kaun, Jose Basilio, et al.
Pageof 35